SkinKandy lists on ASX at US$158.5M valuation after upsized US$103.5M IPO
What's the deal? Australian piercing and jewellery retailer SkinKandy began trading on the ASX on May 21, 2026, opening at US$1.46 per share — above its IPO price of US$1.42. The listing values the company at roughly US$158.5M.
The IPO was upsized to US$103.5M from an initial US$96.4M target after strong investor demand during the bookbuild. It included a US$12.9M capital raise and a sell-down by existing shareholders, including private equity firm Whiteoak Capital. Barrenjoey Markets and Morgans Corporate managed the offering.
Why now? SkinKandy operates more than 100 piercing studios across Australia and New Zealand, positioning itself as a lifestyle retailer for Gen Z and millennial consumers. The company plans to use the listing as a launchpad for international expansion, starting with the US, then the UK and South Africa.
The IPO's pricing at the upper end of its US$1.33–US$1.46 indicative range signals healthy demand, even as broader investor sentiment toward retail remains cautious.
What could go wrong? The listing tests appetite for consumer-facing growth stories in a market where several high-profile IPOs have been delayed or scaled back. SkinKandy's valuation — 10.8 times forecast EBITDA — leaves little room for execution missteps, particularly as it eyes costly international expansion into competitive markets.
The signal: SkinKandy's successful debut suggests public market investors are still willing to back niche consumer brands with clear growth narratives, even amid a sluggish IPO window. Its bet on piercing as a mainstream retail category — and its ambition to take that concept global — will be a test case for whether specialised lifestyle brands can scale beyond their home markets.
Read more: ainvest.com
